Institutional investors purchased a net $1.3 million shares of BGMD during the quarter ended June 2014 and now own 12.91% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WOODSTOCK CORP. Sold 14.8 Thousand shares of BG Medicine Inc